Artificial intelligence, drug repurposing and peer review.

Journal: Nature biotechnology
Published Date: Oct 1, 2020

Abstract

No abstract available for this article.

Authors

  • Jeremy M Levin
    Ovid Therapeutics, Inc, New York, NY, USA.
  • Tudor I Oprea
    Department of Internal Medicine, Translational Informatics Division, University of New Mexico School of Medicine, Albuquerque, NM, USA. toprea@salud.unm.edu.
  • Sagie Davidovich
    SparkBeyond, Netanya, Israel.
  • Thomas Clozel
    OWKIN Paris, France.
  • John P Overington
    BenevolentAI, London, United Kingdom.
  • Quentin Vanhaelen
    Pharmaceutical Artificial Intelligence Department, Insilico Medicine, Inc., Emerging Technology Centers, Johns Hopkins University at Eastern, Baltimore, Maryland, USA.
  • Charles R Cantor
    Boston University, Department of Biomedical Engineering, Boston, Massachusetts, 02215, USA.
  • Evelyne Bischof
    Insilico Medicine, Hong Kong Science and Technology Park, Hong Kong, China. bischofevelyne@gmail.com.
  • Alex Zhavoronkov
    Pharmaceutical Artificial Intelligence Department, Insilico Medicine, Inc., Emerging Technology Centers, Johns Hopkins University at Eastern, Baltimore, Maryland, USA.

Keywords

External Resources

Popular Topics
Recent Journals